"Life Science & Bio Tech"

Life Science & Bio-Tech case study – Mannin GmbH

Mannin GmbH is a wholly-owned subsidiary of a Canadian biotech corporation, Mannin Research Inc. Mannin GmbH was founded in April 2019 as the company’s European headquarters in Leipzig, with the aim of enabling the development and marketing of first-in-class therapeutics to treat various vascular diseases on the German and European healthcare markets. Mannin GmbH is currently involved in developing new drugs for the treatment of vascular disorders, especially glaucoma and infectious diseases (e.g. Covid-19) and has received a multi-million euro grant from regional reconstruction bank SAB for this purpose. Mannin GmbH is an active member of the BioSaxony Cluster.

For more information on Mannin GmbH click here